JP2012522762A5 - - Google Patents

Download PDF

Info

Publication number
JP2012522762A5
JP2012522762A5 JP2012502872A JP2012502872A JP2012522762A5 JP 2012522762 A5 JP2012522762 A5 JP 2012522762A5 JP 2012502872 A JP2012502872 A JP 2012502872A JP 2012502872 A JP2012502872 A JP 2012502872A JP 2012522762 A5 JP2012522762 A5 JP 2012522762A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
group
igfbp7
dermatitis
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012502872A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012522762A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2010/000167 external-priority patent/WO2010113146A1/en
Publication of JP2012522762A publication Critical patent/JP2012522762A/ja
Publication of JP2012522762A5 publication Critical patent/JP2012522762A5/ja
Pending legal-status Critical Current

Links

JP2012502872A 2009-04-01 2010-02-28 ケラチノサイトの増殖および分化を調節する方法 Pending JP2012522762A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20276009P 2009-04-01 2009-04-01
US61/202,760 2009-04-01
PCT/IL2010/000167 WO2010113146A1 (en) 2009-04-01 2010-02-28 A method of regulating proliferation and differentiation of keratinocyes

Publications (2)

Publication Number Publication Date
JP2012522762A JP2012522762A (ja) 2012-09-27
JP2012522762A5 true JP2012522762A5 (enExample) 2013-04-18

Family

ID=42245610

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012502872A Pending JP2012522762A (ja) 2009-04-01 2010-02-28 ケラチノサイトの増殖および分化を調節する方法

Country Status (8)

Country Link
US (1) US8912142B2 (enExample)
EP (1) EP2344179A1 (enExample)
JP (1) JP2012522762A (enExample)
CN (1) CN102448484A (enExample)
AU (1) AU2010231514A1 (enExample)
CA (1) CA2759201A1 (enExample)
MX (1) MX2011010401A (enExample)
WO (1) WO2010113146A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010113146A1 (en) 2009-04-01 2010-10-07 The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center A method of regulating proliferation and differentiation of keratinocyes
US20130123647A1 (en) 2011-05-03 2013-05-16 The Research Foundation Of State University Of New York Methods Useful in Optimizing the Treatment of Neuropathies and Targeting Tissues with Cosmetic Botulinum Injections
US9687669B2 (en) 2011-11-09 2017-06-27 John Stephan Wearable light therapy apparatus
IN2014DN11181A (enExample) * 2012-07-04 2015-10-02 Univ Sydney
DE102013213252A1 (de) * 2013-07-05 2015-01-08 Schülke & Mayr GmbH Verwendung eines Isopropanol enthaltenden Mittels zur Bekämpfung von Caliciviridae
CN106573155A (zh) * 2014-02-26 2017-04-19 鲁玛治疗公司 紫外光疗设备和方法
US11028138B2 (en) * 2016-07-02 2021-06-08 Virongy L.L.C. Compositions and methods for using actin-based peptides to modulate cellular bioactivity and cellular susceptibility to intracellular pathogens
US20190083809A1 (en) 2016-07-27 2019-03-21 Z2020, Llc Componentry and devices for light therapy delivery and methods related thereto
US11147618B2 (en) 2017-01-11 2021-10-19 Medtronic Advanced Energy Llc Electrosurgical unit and system
CN107881240B (zh) * 2017-12-27 2018-10-02 北京泱深生物信息技术有限公司 骨肉瘤的诊治标志物
GB201808723D0 (en) * 2018-05-29 2018-07-11 Univ Birmingham Treatment of hyperproliferative disorders
US12109253B2 (en) 2019-01-30 2024-10-08 Agency For Science, Technology And Research Use of IGFBP7 for treating malaria
WO2021113764A1 (en) * 2019-12-04 2021-06-10 Musc Foundation For Research Development Rnai-based targeting compounds and uses thereof to prevent acquired hearing loss
KR102453894B1 (ko) * 2020-09-15 2022-10-11 (주)아모레퍼시픽 캄페롤 배당체 화합물을 포함하는 피부 보호용 조성물
CN115212302A (zh) * 2022-08-03 2022-10-21 中国人民解放军空军军医大学 抗igfbp7抗体在治疗皮肤病中的应用

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155591A (en) 1961-12-06 1964-11-03 Witco Chemical Corp Hair rinse compostions of polyoxypropylene quaternary ammonium compounds
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3755560A (en) 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3959461A (en) 1974-05-28 1976-05-25 The United States Of America As Represented By The Secretary Of Agriculture Hair cream rinse formulations containing quaternary ammonium salts
DE2437090A1 (de) 1974-08-01 1976-02-19 Hoechst Ag Reinigungsmittel
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4036945A (en) 1976-05-03 1977-07-19 The Massachusetts General Hospital Composition and method for determining the size and location of myocardial infarcts
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
LU76955A1 (enExample) 1977-03-15 1978-10-18
US4331647A (en) 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US4387090A (en) 1980-12-22 1983-06-07 The Procter & Gamble Company Hair conditioning compositions
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5151210A (en) 1985-07-25 1992-09-29 The Procter & Gamble Company Shampoo compositions
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5151209A (en) 1987-11-19 1992-09-29 The Procter & Gamble Company Shampoo compositions
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5011681A (en) 1989-10-11 1991-04-30 Richardson-Vicks, Inc. Facial cleansing compositions
US5120532A (en) 1990-04-06 1992-06-09 The Procter & Gamble Company Hair styling shampoos
ES2108048T3 (es) 1990-08-29 1997-12-16 Genpharm Int Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5073372A (en) 1990-11-30 1991-12-17 Richardson-Vicks, Inc. Leave-on facial emulsion compositions
US5073371A (en) 1990-11-30 1991-12-17 Richardson-Vicks, Inc. Leave-on facial emulsion compositions
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
JP2878528B2 (ja) 1992-07-21 1999-04-05 株式会社日立製作所 磁気記録再生装置
WO1994020063A2 (en) * 1993-03-04 1994-09-15 Cytoven International N.V. Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof
US5667487A (en) 1993-04-07 1997-09-16 Henley; Julian L. Ionosonic drug delivery apparatus
US5541110A (en) 1994-05-17 1996-07-30 Bristol-Myers Squibb Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica
US5807718A (en) 1994-12-02 1998-09-15 The Scripps Research Institute Enzymatic DNA molecules
US5691380A (en) 1995-06-29 1997-11-25 The Procter & Gamble Company Stable n-acetylcysteine compositions and methods for treating human skin therewith
CN1261281A (zh) 1997-05-14 2000-07-26 罗纳·布朗克罗尔药制品有限公司 肽甲状旁腺激素类似物
GB9811171D0 (en) 1998-05-22 1998-07-22 Royal Free Hosp School Med Viral vector
CA2333157A1 (en) * 1998-05-26 1999-12-02 Smithkline Beecham Corporation Novel substituted imidazole compounds
US6348185B1 (en) 1998-06-20 2002-02-19 Washington University School Of Medicine Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
US7393548B2 (en) 1999-03-22 2008-07-01 J.P. M.E.D. Ltd. Nano oil in glycerin emulsion
AUPR030900A0 (en) * 2000-09-22 2000-10-12 Queensland University Of Technology Growth factor complex
CA2590250A1 (en) * 2004-12-14 2006-06-22 Vertex Pharmaceuticals Incorporated Pyrimidine inhibitors of erk protein kinase and uses therof
CA2622852A1 (en) 2005-09-30 2007-04-12 Universiteit Maastricht Tumor angiogenesis associated genes and a method for their identification
WO2009036188A2 (en) 2007-09-11 2009-03-19 University Of Massachusetts Insulin-like growth factor binding protein 7 for treatment of cancer
WO2010113146A1 (en) 2009-04-01 2010-10-07 The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center A method of regulating proliferation and differentiation of keratinocyes

Similar Documents

Publication Publication Date Title
JP2012522762A5 (enExample)
Blakaj et al. Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data
Balamurugan et al. Anti-inflammatory and anti-pyretic activities of earthworm extract—Lampito mauritii (Kinberg)
JP5947721B2 (ja) 変形性関節症を治療するためのジメチルスルホキシド(dmso)およびメチルスルホニルメタン(msm)製剤
Zorzi et al. A phase I study of histone deacetylase inhibitor, pracinostat (SB939), in pediatric patients with refractory solid tumors: IND203 a trial of the NCIC IND program/C17 pediatric phase I consortium
JP2007514750A5 (enExample)
JP2014530873A5 (enExample)
RU2008152341A (ru) Применение аллопуринола для лечения ладонно-подошвенной эритродизестезии
JP2018528259A5 (enExample)
JP2014508758A5 (enExample)
ECSP078014A (es) Regimen de dosificacion para prasugrel
Vasani Facial angiofibromas of tuberous sclerosis treated with topical sirolimus in an Indian patient
Miyazaki et al. Topical morphine gel for pain management in head and neck cancer patients
Kutlar et al. Pomalidomide in sickle cell disease: phase I study of a novel anti-switching agent
CA2928675C (en) Method for the management of cancer and cancer treatment-related comorbidities
WO2004043336A3 (en) Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases
JP2010505827A5 (enExample)
CN101837068B (zh) 椒目仁油喷雾剂的制备工艺和应用
CN102293816B (zh) 一种治疗风湿病的滴丸的制备方法
CN112843146A (zh) 中成药三黄膏的新用途
CN104174009A (zh) 一种蝇蛆蛋白制剂及用途
BRPI0902144A2 (pt) processo para preparar uma composição farmacêutica sólida, de administração por via oral que contém os prìncipios ativos glicosamina e meloxicam e uso da associação entre glicosamina e meloxicam
CN100434080C (zh) 一种治疗皮肤病的药物
WO2019072353A1 (en) TOPICAL PHARMACEUTICAL PREPARATION OF BETAMETHASONE, CALCIPOTRIOL AND ROSE OIL FOR THE TREATMENT OF PSORIASIS
JP2019529554A5 (enExample)